CYTOALLOSURVEY
A Prospective, Multicenter Survey of Cytomegalovirus (CMV) and Other Herpesviruses Infections and Diseases in Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Recipients.
Sponsor study identifier
observational
1,310
1 country
50
Study Start
January 1, 2021
Actual (reported)Primary Completion
July 31, 2022
Actual (reported)Study Completion
March 31, 2023
Actual (reported)Prospective observational study of epidemiological surveillance, multicenter, non-profit, spontaneous, Italian with objective to describe the incidence of CMV infections and diseases in adult and pediatric patients undergoing allo-HSCT during the first 6 months from transplant. This study will evaluate approximately 1500 subjects (with competitive enrolment) from GITMO investigational centers.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 31, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 29, 2020
Actual (reported)June 2, 2020
Actual (reported)January 1, 2021
Actual (reported)July 31, 2022
Actual (reported)March 31, 2023
Actual (reported)Cytomegalovirus infection
incidence of Cytomegalovirus after allogeneic haematopoietic stem cell transplantation
6 months from transplant
Cytomegalovirus disease
incidence of Cytomegalovirus after allogeneic haematopoietic stem cell transplantation
6 months from transplant
Herpesvirus human 6 infection
incidence of human 6 infection after allogeneic haematopoietic stem cell transplantation
6 months from transplant
Adult and children allogenic Hematopoietic stem cell transplantation recipients
Adult and children allogenic Hematopoietic stem cell transplantation recipients
Ospedale San Carlo
Potenza, Italy, Italy
Policlinico GB Rossi
Verona, Italy, Italy
UO Ematologia e TMO - Ospedale C. Panico
Tricase, Lecce, Italy
A.O.U. Policlinico Federico II
Naples, Napoli, Italy
Fondazione IRCCS San Matteo
Pavia, Pavia, 27100, Italy
Azienda Ospedaliero-Universitaria Ospedali Riuniti
Ancona, Italy
Ospedale Mazzoni
Ascoli Piceno, Italy
Girmenia C, Chiusolo P, Marsili G, Piciocchi A, Mico MC, Greco R, Porto G, Galaverna F, Bonifazi F, Cutini I, Malagola M, Bramanti S, Busca A, Carella AM, Carotti A, Iori AP, Onida F, Bono R, Terruzzi E, Vacca A, Rinaldi A, Cavattoni IM, Picardi A, Faraci M, Lazzarotto T, Baldanti F, Clerici P, Castagna L, Martino M, Ciceri F. The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis. Open Forum Infect Dis. 2025 Apr 18;12(5):ofaf233. doi: 10.1093/ofid/ofaf233. eCollection 2025 May.
Corrado Girmenia
Azienda Policlinico Umberto I
1,310 participants (actual enrollment reported by the registry).
First Submitted
May 29, 2020
First Posted
June 2, 2020
Study Start
January 1, 2021
Actual (reported)AI Algorithms to Automate the TMI by VMAT Optimization Using WB-CT/MRI and Synthetic WB-CT - The AuToMI Project
Herpesvirus human 6 disease
incidence of human 6 disease after allogeneic haematopoietic stem cell transplantation
6 months from transplant
Virus Epstein-Barr infection
incidence of Virus Epstein-Barr infections after allogeneic haematopoietic stem cell transplantation
6 months from transplant
Virus Epstein-Barr disease
incidence of Virus Epstein-Barr disease after allogeneic haematopoietic stem cell transplantation
6 months from transplant
Overall Survival (OS)
These outcome measures will be assessed at 1 year from transplant
Disease Free Survival (DFS)
These outcome measures will be assessed at 1 year from transplant
Transplant Related Mortality (TRM)
These outcome measures will be assessed at 1 year from transplant
Relapse risk (RR)
These outcome measures will be assessed at 1 year from transplant
Acute Graft-versus-Host Disease
These outcome measures will be assessed at 100 days from transplant
Contact the study team to confirm eligibility.
A.O.S. G. Moscati
Avellino, Italy
Policlinico di Bari-Ematologia con trapianti
Bari, Italy
Divisione di Ematologia - Ospedali Papa Giovanni XXIII
Bergamo, Italy
A.O.U. Policlinico S.Orsola-Malpighi
Bologna, Italy
Ospedale San Orsola
Bologna, Italy
Ospedale Regionale Generale- Divisione Ematologia
Bolzano, Italy
AO Spedali Civili di Brescia- USD - TMO Adulti
Brescia, Italy
Azienda Sanitaria Locale Br1 Ospedale "A. Perrino
Brindisi, Italy
CTMO PO "Businco" A.O. "G. Brotzu"
Cagliari, Italy
Ospedale Ferrarotto
Catania, Italy
Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle
Cuneo, Italy
Azienda Ospedaliera di Careggi
Florence, Italy
Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza
Foggia, Italy
AOU-IRCCS San Martino-IST
Genova, Italy
Ospedale Gaslini
Genova, Italy
Policlinico VIto Fazzi
Lecce, Italy
AOU Integrata
Mestre, Italy
Divisione di Ematologia - Istituto Nazionale dei Tumori
Milan, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
Ospedale San Raffaele
Milan, Italy
Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico -
Modena, Italy
Ospedale San Gerardo
Monza, Italy
AOU S. Giovanni di Dio e Ruggi D'Aragona
Naples, Italy
Uoc Sit Tmo
Naples, Italy
UOSC Ematologia con Trapianto CSE, AORN A. Cardarelli, AORN Cardarelli
Naples, Italy
Azienda Ospedaliera di Padova
Padova, Italy
CTMO Osp. V. Cervello Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello
Palermo, Italy
Azienda ospedaliera Universitaria di Parma
Parma, Italy
Policlinico San Matteo
Pavia, Italy
Ospedale S. Maria della Misericordia
Perugia, Italy
Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara
Pescara, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Centro Unico Regionale Trapianti di Midollo Osseo - Ospedale Bianchi-Melacino-Morelli
Reggio Calabria, Italy
Arciospedale S. M. Novella
Reggio Emilia, Italy
Divisione di Ematologia - Istituto di Semeiotica Medica - Policlinico A. Gemelli
Roma, Italy
Ospedale Bambin Gesù
Roma, Italy
Policlinico Tor Vergata
Roma, Italy
Policlinico Umberto I
Roma, Italy
Dipartimento di Oncologia Medica ed Ematologia - Istituto Clinico Humanitas
Rozzano (MI), Italy
Ospedale Moscati
Taranto, Italy
AOU CIttà della Salute e della Scienza
Torino, Italy
Ospedale Regina Margherita
Torino, Italy
A.O. Santa Maria della Misericordia
Udine, Italy
Primary Completion
July 31, 2022
Actual (reported)Study Completion
March 31, 2023
Actual (reported)Last Updated
January 6, 2025
Record last verified: 2025-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: